Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United States Antimony (UAMY) Asset Writedowns and Impairment (2020 - 2024)

Historic Asset Writedowns and Impairment for United States Antimony (UAMY) over the last 8 years, with Q4 2024 value amounting to $2073.0.

  • United States Antimony's Asset Writedowns and Impairment fell 9990.0% to $2073.0 in Q4 2024 from the same period last year, while for Jun 2025 it was $55146.0, marking a year-over-year decrease of 9780.39%. This contributed to the annual value of $65647.0 for FY2024, which is 9683.39% down from last year.
  • United States Antimony's Asset Writedowns and Impairment amounted to $2073.0 in Q4 2024, which was down 9990.0% from $53073.0 recorded in Q3 2024.
  • United States Antimony's 5-year Asset Writedowns and Impairment high stood at $2.1 million for Q4 2023, and its period low was -$132773.0 during Q4 2022.
  • For the 5-year period, United States Antimony's Asset Writedowns and Impairment averaged around $203096.4, with its median value being $37774.0 (2020).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first surged by 166161.57% in 2023, then tumbled by 9990.0% in 2024.
  • United States Antimony's Asset Writedowns and Impairment (Quarter) stood at -$22475.0 in 2020, then crashed by 193.9% to -$66054.0 in 2021, then crashed by 101.01% to -$132773.0 in 2022, then soared by 1661.62% to $2.1 million in 2023, then plummeted by 99.9% to $2073.0 in 2024.
  • Its Asset Writedowns and Impairment stands at $2073.0 for Q4 2024, versus $53073.0 for Q3 2024 and -$112716.0 for Q2 2024.